Calreticulin mutant mice develop essential thrombocythemia that is ameliorated by the JAK inhibitor ruxolitinib - Concepedia

Concepedia

Publication | Open Access

Calreticulin mutant mice develop essential thrombocythemia that is ameliorated by the JAK inhibitor ruxolitinib

DOI Full Paper Access

71

Citations

34

References

2016

Year

Kotaro Shide, Takuro Kameda, Takumi Yamaji, Masaaki Sekine, Naomi Inada, Ayako Kamiunten, Keiichi Akizuki, Kenichi Nakamura, Tomonori Hidaka, Yoko Kubuki,

References

	Year	Citations

Page 1